Showing 1–14 of 14 results
-
-
-
-
-
-
-
-
-
Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up
- M Bontenbal
- , JA Foekens
- , SWJ Lamberts
- , FH de Jong
- , WLJ van Putten
- , HJ Braun
- , JThM Burghouts
- , GHM van der Linden
- & JGM Klijn
British Journal of Cancer 77 , 115–122 -
-
External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts
- CGJ Sweep
- , J Geurts-Moespot
- , N Grebenschikov
- , JH de Witte
- , JJTM Heuvel
- , M Schmitt
- , MJ Duffy
- , F Jänicke
- , MD Kramer
- , JA Foekens
- , N Brünner
- , G Brugal
- , AN Pedersen
- & ThJ Benraad
British Journal of Cancer 78 , 1434–1441 -
-
-
